#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Blood iron increased Porphyria non-acute Basal cell naevus syndrome Oesophageal carcinoma Crigler-Najjar syndrome Epileptic encephalopathy Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome Leukoencephalopathy White matter lesion Essential thrombocythaemia Becker's muscular dystrophy Hypomagnesaemia Malignant fibrous histiocytoma Glycogen storage disease type V Primary amyloidosis More trials…

    Learn about Rare Diseases

    Chondrosarcoma metastatic Pulmonary fibrosis – Life with Disease Brain stem glioma – Trials in Disease MELAS syndrome – Treatment Cystic fibrosis Haemophilia A without inhibitors – Trials in Disease Short-bowel syndrome – Treatment Myelodysplastic syndrome with excess blasts – Treatment Gastrointestinal stromal tumour – Treatment Splenic marginal zone lymphoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Poloxamer 407 Eribulin Mesylate Paroxetine Hydrochloride Mesalazine INSULIN DETEMIR Nortriptyline Hydrochloride Zamtocabtagene Autoleucel Thiotepa Avb-101 Anhydrous Cidofovir Entinostat Obeticholic Acid Simvastatin Imlifidase Adct-402 Oxymetazoline Hydrochloride Minocycline Hydrochloride Bi 764524 Absk021 Hydrochloride Hydrate Baloxavir Marboxil More therapies…

    Learn about Your Condition

    Mixed-type liposarcoma Medication overuse headache Hypoglycaemia Multifocal motor neuropathy Deafness neurosensory Liposarcoma recurrent Anogenital dysplasia Microscopic polyangiitis Precocious puberty Anal squamous cell carcinoma Mesothelioma Uterine leiomyoma Breast cancer stage II Diverticulitis Liposarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on Spinal Morphine, Intravenous Lidocaine, and Bupivacaine for Patients Undergoing Robot-Assisted Surgery for Kidney or Ureter Conditions

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Anhydrous Lidocaine Hydrochloride
    • Bupivacaine Hydrochloride, Anhydrous
    • Extract Of Fresh Opium Poppy (1:2.2-2.7), Extraction Solvent: Ethanol 31.2 % (M/M)
    Sweden

  • Study on Treating Acute Myeloid Leukemia in Children and Adolescents Using Gemtuzumab Ozogamicin and a Drug Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Dexrazoxane
    • Gemtuzumab Ozogamicin
    • Etoposide Phosphate
    Belgium Denmark Estonia Finland Iceland Latvia +6

  • Study on Cobicistat, Venetoclax, and Azacitidine for Patients with Newly Diagnosed Acute Myeloid Leukemia Ineligible for Intensive Chemotherapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Cobicistat
    • Azacitidine
    • Venetoclax
    The Netherlands

  • Study on Monitoring vs. Rivaroxaban for Patients with Low-Risk Isolated Subsegmental Pulmonary Embolism

    Recruiting

    3 1 1
    Investigated Drugs:
    • Rivaroxaban
    Belgium France The Netherlands

  • Study on the Use of Allogenic Adipose-Tissue-Derived Mesenchymal Stem Cells for Healing Chronic Digital Ulcers in Systemic Sclerosis Patients

    Recruiting

    2 1
    Investigated Diseases:
    • Systemic scleroderma
    France

  • Study on Zanubrutinib and Rituximab for Patients with IgM Monoclonal Gammopathy and MAG Antibodies-Related Polyneuropathy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Anti-myelin-associated glycoprotein associated polyneuropathy
    Investigated Drugs:
    • Zanubrutinib
    The Netherlands
Previous Page
1 … 542 543 544 545 546 … 1,655
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!